IP Library Granted Patent US 6,867,333
Granted Patent B2
US 6,867,333 · App. 10/414,510 · Granted Mar 15, 2005

EPOTHILONE SYNTHESIS BUILDING BLOCKS III AND IV: ASYMMETRICALLY SUBSTITUTED ACYLOINS AND ACYLOIN DERIVATIVES, METHODS FOR THEIR PRODUCTION AND METHODS FOR THE PRODUCTION OF EPOTHILONES B, D AND EPOTHILONE DERIVATIVES

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,867,333
App. No.
10/414,510
Granted
Mar 15, 2005
Kind
B2
Abstract

The present invention is directed to novel acyloins, their derivatives, methods for their production and their use for the production of novel epothilones and their derivatives. In addition, the invention is directed to the building blocks for epothilone synthesis, methods for their production and the use of synthetic building blocks for the production of epothilones and their derivatives.

Claims (44)

1. An α-hydroxy ketone and/or α-hydroxy aldehyde compound of the general formula I:

wherein

R 1 is selected from the group consisting of H, methyl, CH n F 3-n (n=0-3), ethyl or propyl;

B 1 and/or B 2 stands for a single or double bond in the E-(trans) form, Z-(cis) form or E/Z-mixture; or an epoxide as E-(trans) form, Z-(cis) form or E/Z mixture and/or combinations thereof;

R 4 is H, methyl, ethyl, CH n F 3-n (n=0-3), or halogen;

R 5 is H or PG;

Nu is H or alkyl;

E is CH 3 , CH 2 OH, CH 2 OPG, CO 2 PG, CO 2 R or CH═O;

R is H, methyl or ethyl; and

PG designates a conventional protective group for the given coupling atom or the given functional group.

2. The compound according to claim 1 , wherein B 1 stands for a double bond in Z form or an epoxide.

3. The compound according to claim 1 or 2 , wherein R 1 is methyl.

4. The compound according to claim 1 , wherein B 2 stands for a single bond.

5. The compound according to claim 1 , wherein PG is selected from the froup consisting of: allyl, t-butyl, methyl, benzyl, silyl, acyl, an activated methylene derivative, methoxymethyl, alkoxyalkyl, 2-oxacycloalkyl, trimethylsilyl, triethylsilyl, dimethyl-tert-butylsilyl, acetyl, propionyl, benzoyl and tetrahydropyranyl.

6. The compound according to claim 1 , wherein the compound is not racemic, i.e. is optically active at the α-hydroxy position (at position 15) of the general formula I.

7. The compound according to claim 6 , wherein the absolute configuration of the α-hydroxy position of the general formula I (at position 15) corresponds to the natural configuration of epothilones at position C15.

8. The compound according to claim 1 , wherein the protective group PG is selected from the group consisting of: acetyl, propionyl, butyroyl and benzoyl groups.

9. The compound according to claim 1 , wherein the α-hydroxy group (at position 15) of the general formula I is protected by a non-racemic chiral acyl group.

10. The compound according to claim 9 , wherein the α-hydroxy group (at position 15) of the general formula I is esterified with optically active 2-methoxy mandelic acid.

11. A method for synthesising compounds according to claim 1 , comprising at least one of the following steps:

(a) reacting compounds of general formula II

wherein R 3 is selected from the group consisting of: alkyl, benzyl and phenyl or is a chiral, non-racemic residue R*; and

EWG is CO 2 PG;

with an allyl derivative of type A (coupled at X)

wherein X is selected from the group consisting of: Cl, Br, I, O-tosyl, methyl sulfonate, trifluor methyl sulfonate, alkanoates and aryl carboxylates;

to compounds with the general formula III

(b) performing a conversion of compounds of the general formula III to compounds of the general formula IV

by alkyl decarboxylation, sponification or decarboxylation;

(c) performing a solvolysis of the compound of general formula IV to free α-hydroxy ketones of the general formula I; and/or

(d) performing a racemate separation by esterification of compounds of the general formula I.

12. The method according to claim 11 , wherein R 3 is non-racemic chiral acyl group.

13. The method according to claim 11 , wherein the production of compounds of the general formula I or IV, which are non-racemic at the α-hydroxy position, is performed by separation of the racemates by enzymatic esterification.

14. The method according to claim 13 , wherein the esterification is performed in the presence of an enzyme selected from the group consisting of lipases and esterases.

15. The method according to claim 14 , wherein lipases from Pseudomonas cepacia and/or Candida antarctica or esterases from Pseudomonas fluorescens and/or Streptomyces diastatochromogenes are used.

16. The method according to claim 11 , wherein the production of compounds of the general formula I or IV, which are non-racemic at the α-hydroxy position, is performed by enzymatic hydrolytic racemate separation of compounds of type IV.

17. The method according to claim 16 , wherein hydrolysis is performed in the presence of an enzyme selected from the group consisting of: lipases and esterases.

18. The method according to claim 17 , wherein lipases from Pseudomonas cepacia and/or Candida antarctica or esterases from Pseudomonas fluorescens and/or Streptomyces diastatochromogenes are used.

19. A compound of the general formula XII

wherein

B 1 is a single or double bond;

E is selected from the group consisting of CH 2 OH, CH 2 OPG and CH═O;

X′ is selected from the group consisting of Cl, Br, I, O-tosyl, methyl sulfonate, trifluor methyl sulfonate, alkanoates and aryl carboxylates;

Z′ is O or OPG; and

PG is a protective group.